GLORIA GOORAY: Open Payments
NPI 1285398081 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,615 in 76 payments from 16 companies in 2025. Trend: 2023 $101 · 2024 $482 · 2025 $2,615
Food & beverage: $2,305Education: $310
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $843 |
| Arcutis Biotherapeutics, Inc. | 6 | $241 |
| UCB, Inc. | 6 | $216 |
| Regeneron Healthcare Solutions, Inc. | 6 | $209 |
| ABBVIE INC. | 14 | $196 |
| GENZYME CORPORATION | 7 | $182 |
| Galderma Laboratories, L.P. | 4 | $159 |
| PFIZER INC. | 6 | $150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $126 |
| Novartis Pharmaceuticals Corporation | 2 | $99 |
Products named: TREMFYA, DUPIXENT, Zoryve, Bimzelx, SKYRIZI, CIBINQO, NEMLUVIO, COSENTYX.
Industry payments across MD — which companies pay providers there.
